PRECISEU Matchmaking Platform

20 Oct 2025 – 30 Apr 2026 | Barcelona, Spain

Register
Register
Register

Business OpportunityUpdated on 20 March 2026

Tel-eVax

CEO at Evvivax srl

Roma, Italy

About

Tel-eVax is a genetic vaccine that targets the telomerase enzyme (TERT), overexpressed in tumor cells, to stimulate an antitumor immune response. It has been shown to be safe, immunogenic, and to increase survival in over 100 dogs with B-cell lymphoma in Italy and the USA when combined with standard chemotherapy, with potential application in other tumors and human models.

Organisation

Evvivax srl

SME

Roma, Italy

Similar opportunities